+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Clinical Safety & Pharmacovigilance Services Market - Global Forecast 2025-2030- Product Image
Clinical Safety & Pharmacovigilance Services Market - Global Forecast 2025-2030- Product Image
Sale

Clinical Safety & Pharmacovigilance Services Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 190 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6129626
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Senior leaders navigating the clinical safety and pharmacovigilance landscape face increasing complexity from global trials, regulatory scrutiny, and advanced therapeutics. Proactive surveillance systems, technology adoption, and strategic market adaptation are redefining competitive advantage and operational resilience in this sector.

Market Snapshot: Clinical Safety and Pharmacovigilance Market Overview

The clinical safety and pharmacovigilance market is experiencing robust growth driven by expanded global clinical trials, innovation in real-world data utilization, and higher regulatory expectations. Organizations are increasingly prioritizing proactive safety monitoring and risk mitigation strategies. Integrated platforms leveraging automation and artificial intelligence are now essential for timely identification of adverse events and enduring regulatory compliance. This transition from reactive to proactive risk management is creating opportunities for contract research organizations (CROs), pharmaceutical manufacturers, and regulatory bodies to enhance operational efficiency and stakeholder trust.

Scope and Segmentation

This research delivers in-depth analysis of the clinical safety and pharmacovigilance market, structured by service type, end user, trial phase, therapeutic area, deployment mode, and region:

  • Service Types: Audit inspection readiness (including mock inspection drills and pre-audit assessments), case processing (covering individual case safety reports and literature screening), regulatory intelligence (incorporating labeling support and compliance advisory), risk management (encompassing risk evaluation and mitigation), and signal detection (aggregate and proactive signal monitoring).
  • End Users: Large and small CROs, large and small medical device manufacturers, large pharmaceutical firms, small biotech companies, and regulatory authorities.
  • Clinical Trial Phases: Phase I (healthy and patient volunteers), Phase II (dose escalation and proof of concept), Phase III (confirmatory and pivotal studies), Phase IV (observational and post-marketing surveillance).
  • Therapeutic Areas: Cardiovascular (arrhythmia, heart failure), central nervous system (Alzheimer’s, depression), infectious diseases (bacterial, viral), oncology (hematologic malignancies, solid tumors).
  • Deployment Modes: Cloud (hybrid, private, public) and on-premise solutions (managed and self-hosted options).
  • Geographies Covered: Americas (including United States regions such as California, Texas, New York, Florida, and more), Europe (United Kingdom, Germany, France, and others), Middle East & Africa (e.g., United Arab Emirates, South Africa), and Asia-Pacific (including China, India, Japan, Australia, and further regions).
  • Key Companies Assessed: IQVIA Holdings Inc., Laboratory Corporation of America Holdings, Thermo Fisher Scientific Inc., Parexel International Corporation, ICON plc, Syneos Health, Inc., Accenture plc, Cognizant Technology Solutions Corporation, Wipro Limited, Genpact Limited.

Key Takeaways

  • Adoption of advanced analytics and AI is transforming signal detection, enabling earlier risk identification and streamlined case processing.
  • Regulatory bodies across multiple regions are intensifying inspection readiness demands, leading organizations to invest in continuous compliance frameworks and audit practices.
  • Segmented service needs drive strategic differentiation, as large CROs invest in scalable technology while smaller firms deploy flexible, managed-hosting solutions for agility.
  • Therapeutic area specialization, particularly in oncology and infectious diseases, is resulting in customized vigilance workflows and nuanced risk management approaches.
  • Deployment modes are shifting, with cloud-based and hybrid models offering scalability and cross-regional collaboration, while on-premise solutions remain crucial for data security in certain jurisdictions.

Tariff Impact on the U.S. Pharmacovigilance Market

Heightened tariffs on imported pharmacovigilance tools and outsourcing in the United States are influencing operational designs and cost structures. Organizations are increasing investments in domestic resources for compliance services, seeking nearshore alternatives, and realigning procurement strategies. This has accelerated adoption of automation, promoted investment in local talent, and seen a shift toward geographically diversified networks. The interplay of trade policy and safety operations is requiring agile governance and resilient supply chains while prioritizing patient safety objectives.

Methodology & Data Sources

This comprehensive analysis is based on primary interviews with pharmacovigilance experts, regulatory officials, and industry leaders. It integrates secondary research from regulatory guidelines, peer-reviewed literature, white papers, and public data. Advanced analytics tools were applied to aggregate and validate findings. Peer reviews and cross-regional benchmarking ensure accuracy and credibility.

Why This Report Matters

  • Provides senior decision-makers with actionable insights to optimize regulatory strategies, risk management, and technology investments in clinical safety and pharmacovigilance.
  • Uncovers region-specific trends, tariff-driven shifts, and competitive strategies essential for maintaining operational integrity and market leadership.

Conclusion

This report delivers senior leaders a practical framework for adapting to evolving requirements in clinical safety and pharmacovigilance. By leveraging strategic findings, organizations can drive compliance, innovation, and resilient growth in a dynamic global market.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of artificial intelligence and machine learning for automated adverse event signal detection and triage in pharmacovigilance workflows
5.2. Expansion of real-world data sources including social media and wearable devices for proactive safety surveillance and risk assessment
5.3. Deployment of blockchain-based patient data tracking systems to enhance transparency and traceability in clinical safety reporting processes
5.4. Implementation of cloud-native pharmacovigilance platforms to support global data integration and scalable regulatory compliance operations
5.5. Adoption of centralized safety review dashboards with interactive visualization for cross-functional collaboration and decision-making
5.6. Utilization of natural language processing to extract and codify safety information from unstructured clinical narratives and electronic health records
5.7. Shift towards decentralized clinical trials requiring robust remote monitoring of adverse events and virtual patient engagement strategies
5.8. Increasing regulatory emphasis on benefit-risk optimization through advanced quantitative methods and dynamic risk management plans
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Clinical Safety & Pharmacovigilance Services Market, by Service Type
8.1. Introduction
8.2. Audit Inspection Readiness
8.2.1. Mock Inspection Drills
8.2.2. Pre Audit Assessment
8.3. Case Processing
8.3.1. ICSRs
8.3.2. Literature Screening
8.4. Regulatory Intelligence
8.4.1. Labeling Support
8.4.2. Regulatory Compliance
8.5. Risk Management
8.5.1. Risk Evaluation
8.5.2. Risk Mitigation
8.6. Signal Detection
8.6.1. Aggregate Signal Detection
8.6.2. Proactive Signal Detection
9. Clinical Safety & Pharmacovigilance Services Market, by End User
9.1. Introduction
9.2. CRO
9.2.1. Large CRO
9.2.2. Small CRO
9.3. Medical Device Manufacturers
9.3.1. Large Device Firms
9.3.2. Small Device Firms
9.4. Pharma Biotech
9.4.1. Large Pharma
9.4.2. Small Biotech
9.5. Regulatory Authorities
10. Clinical Safety & Pharmacovigilance Services Market, by Clinical Trial Phase
10.1. Introduction
10.2. Phase I
10.2.1. Healthy Volunteers
10.2.2. Patient Volunteers
10.3. Phase II
10.3.1. Dose Escalation
10.3.2. Proof Of Concept
10.4. Phase III
10.4.1. Confirmatory
10.4.2. Pivotal
10.5. Phase IV
10.5.1. Observational
10.5.2. Post Marketing
11. Clinical Safety & Pharmacovigilance Services Market, by Therapeutic Area
11.1. Introduction
11.2. Cardiovascular
11.2.1. Arrhythmia
11.2.2. Heart Failure
11.3. CNS
11.3.1. Alzheimer
11.3.2. Depression
11.4. Infectious Diseases
11.4.1. Bacterial
11.4.2. Viral
11.5. Oncology
11.5.1. Hematologic Malignancies
11.5.2. Solid Tumors
12. Clinical Safety & Pharmacovigilance Services Market, by Deployment Mode
12.1. Introduction
12.2. Cloud
12.2.1. Hybrid Cloud
12.2.2. Private Cloud
12.2.3. Public Cloud
12.3. On Premise
12.3.1. Managed Hosting
12.3.2. Self Hosted
13. Americas Clinical Safety & Pharmacovigilance Services Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Clinical Safety & Pharmacovigilance Services Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Clinical Safety & Pharmacovigilance Services Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. IQVIA Holdings Inc.
16.3.2. Laboratory Corporation of America Holdings
16.3.3. Thermo Fisher Scientific Inc.
16.3.4. Parexel International Corporation
16.3.5. ICON plc
16.3.6. Syneos Health, Inc.
16.3.7. Accenture plc
16.3.8. Cognizant Technology Solutions Corporation
16.3.9. Wipro Limited
16.3.10. Genpact Limited
17. ResearchAI18. ResearchStatistics19. ResearchContacts20. ResearchArticles21. Appendix
List of Figures
FIGURE 1. CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY CLINICAL TRIAL PHASE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY CLINICAL TRIAL PHASE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY DEPLOYMENT MODE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY DEPLOYMENT MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET: RESEARCHAI
FIGURE 26. CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET: RESEARCHSTATISTICS
FIGURE 27. CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET: RESEARCHCONTACTS
FIGURE 28. CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY AUDIT INSPECTION READINESS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY AUDIT INSPECTION READINESS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY MOCK INSPECTION DRILLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY MOCK INSPECTION DRILLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY PRE AUDIT ASSESSMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY PRE AUDIT ASSESSMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY AUDIT INSPECTION READINESS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY AUDIT INSPECTION READINESS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY CASE PROCESSING, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY CASE PROCESSING, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY ICSRS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY ICSRS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY LITERATURE SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY LITERATURE SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY CASE PROCESSING, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY CASE PROCESSING, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY REGULATORY INTELLIGENCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY REGULATORY INTELLIGENCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY LABELING SUPPORT, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY LABELING SUPPORT, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY REGULATORY COMPLIANCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY REGULATORY COMPLIANCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY REGULATORY INTELLIGENCE, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY REGULATORY INTELLIGENCE, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY RISK MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY RISK MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY RISK EVALUATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY RISK EVALUATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY RISK MITIGATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY RISK MITIGATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY RISK MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY RISK MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY SIGNAL DETECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY SIGNAL DETECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY AGGREGATE SIGNAL DETECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY AGGREGATE SIGNAL DETECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY PROACTIVE SIGNAL DETECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY PROACTIVE SIGNAL DETECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY SIGNAL DETECTION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY SIGNAL DETECTION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY CRO, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY CRO, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY LARGE CRO, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY LARGE CRO, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY SMALL CRO, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY SMALL CRO, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY CRO, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY CRO, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY MEDICAL DEVICE MANUFACTURERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY MEDICAL DEVICE MANUFACTURERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY LARGE DEVICE FIRMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY LARGE DEVICE FIRMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY SMALL DEVICE FIRMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY SMALL DEVICE FIRMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY MEDICAL DEVICE MANUFACTURERS, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY MEDICAL DEVICE MANUFACTURERS, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY PHARMA BIOTECH, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY PHARMA BIOTECH, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY LARGE PHARMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY LARGE PHARMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY SMALL BIOTECH, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY SMALL BIOTECH, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY PHARMA BIOTECH, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY PHARMA BIOTECH, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY REGULATORY AUTHORITIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY REGULATORY AUTHORITIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY CLINICAL TRIAL PHASE, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY CLINICAL TRIAL PHASE, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY PHASE I, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY PHASE I, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY HEALTHY VOLUNTEERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY HEALTHY VOLUNTEERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY PATIENT VOLUNTEERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY PATIENT VOLUNTEERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY PHASE I, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY PHASE I, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY PHASE II, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY PHASE II, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY DOSE ESCALATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY DOSE ESCALATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY PROOF OF CONCEPT, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY PROOF OF CONCEPT, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY PHASE II, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY PHASE II, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY PHASE III, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY PHASE III, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY CONFIRMATORY, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY CONFIRMATORY, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY PIVOTAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY PIVOTAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY PHASE III, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY PHASE III, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY PHASE IV, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY PHASE IV, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY OBSERVATIONAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY OBSERVATIONAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY POST MARKETING, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY POST MARKETING, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY PHASE IV, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY PHASE IV, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY ARRHYTHMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY ARRHYTHMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY HEART FAILURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY HEART FAILURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY CNS, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY CNS, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY ALZHEIMER, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY ALZHEIMER, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY DEPRESSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY DEPRESSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY CNS, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY CNS, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY BACTERIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY VIRAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY VIRAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 141. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY HEMATOLOGIC MALIGNANCIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 142. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY HEMATOLOGIC MALIGNANCIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 143. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 144. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY SOLID TUMORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 145. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 146. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 147. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 148. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 149. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY CLOUD, BY REGION, 2018-2024 (USD MILLION)
TABLE 150. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY CLOUD, BY REGION, 2025-2030 (USD MILLION)
TABLE 151. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY HYBRID CLOUD, BY REGION, 2018-2024 (USD MILLION)
TABLE 152. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY HYBRID CLOUD, BY REGION, 2025-2030 (USD MILLION)
TABLE 153. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY PRIVATE CLOUD, BY REGION, 2018-2024 (USD MILLION)
TABLE 154. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY PRIVATE CLOUD, BY REGION, 2025-2030 (USD MILLION)
TABLE 155. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY PUBLIC CLOUD, BY REGION, 2018-2024 (USD MILLION)
TABLE 156. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY PUBLIC CLOUD, BY REGION, 2025-2030 (USD MILLION)
TABLE 157. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
TABLE 158. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY CLOUD, 2025-2030 (USD MILLION)
TABLE 159. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY ON PREMISE, BY REGION, 2018-2024 (USD MILLION)
TABLE 160. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY ON PREMISE, BY REGION, 2025-2030 (USD MILLION)
TABLE 161. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY MANAGED HOSTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 162. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY MANAGED HOSTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 163. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY SELF HOSTED, BY REGION, 2018-2024 (USD MILLION)
TABLE 164. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY SELF HOSTED, BY REGION, 2025-2030 (USD MILLION)
TABLE 165. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY ON PREMISE, 2018-2024 (USD MILLION)
TABLE 166. GLOBAL CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY ON PREMISE, 2025-2030 (USD MILLION)
TABLE 167. AMERICAS CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 169. AMERICAS CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY AUDIT INSPECTION READINESS, 2018-2024 (USD MILLION)
TABLE 170. AMERICAS CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY AUDIT INSPECTION READINESS, 2025-2030 (USD MILLION)
TABLE 171. AMERICAS CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY CASE PROCESSING, 2018-2024 (USD MILLION)
TABLE 172. AMERICAS CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY CASE PROCESSING, 2025-2030 (USD MILLION)
TABLE 173. AMERICAS CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY REGULATORY INTELLIGENCE, 2018-2024 (USD MILLION)
TABLE 174. AMERICAS CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY REGULATORY INTELLIGENCE, 2025-2030 (USD MILLION)
TABLE 175. AMERICAS CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY RISK MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 176. AMERICAS CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY RISK MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 177. AMERICAS CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY SIGNAL DETECTION, 2018-2024 (USD MILLION)
TABLE 178. AMERICAS CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY SIGNAL DETECTION, 2025-2030 (USD MILLION)
TABLE 179. AMERICAS CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 180. AMERICAS CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 181. AMERICAS CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY CRO, 2018-2024 (USD MILLION)
TABLE 182. AMERICAS CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY CRO, 2025-2030 (USD MILLION)
TABLE 183. AMERICAS CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY MEDICAL DEVICE MANUFACTURERS, 2018-2024 (USD MILLION)
TABLE 184. AMERICAS CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY MEDICAL DEVICE MANUFACTURERS, 2025-2030 (USD MILLION)
TABLE 185. AMERICAS CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY PHARMA BIOTECH, 2018-2024 (USD MILLION)
TABLE 186. AMERICAS CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY PHARMA BIOTECH, 2025-2030 (USD MILLION)
TABLE 187. AMERICAS CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY CLINICAL TRIAL PHASE, 2018-2024 (USD MILLION)
TABLE 188. AMERICAS CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY CLINICAL TRIAL PHASE, 2025-2030 (USD MILLION)
TABLE 189. AMERICAS CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY PHASE I, 2018-2024 (USD MILLION)
TABLE 190. AMERICAS CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY PHASE I, 2025-2030 (USD MILLION)
TABLE 191. AMERICAS CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY PHASE II, 2018-2024 (USD MILLION)
TABLE 192. AMERICAS CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY PHASE II, 2025-2030 (USD MILLION)
TABLE 193. AMERICAS CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY PHASE III, 2018-2024 (USD MILLION)
TABLE 194. AMERICAS CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY PHASE III, 2025-2030 (USD MILLION)
TABLE 195. AMERICAS CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY PHASE IV, 2018-2024 (USD MILLION)
TABLE 196. AMERICAS CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY PHASE IV, 2025-2030 (USD MILLION)
TABLE 197. AMERICAS CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 198. AMERICAS CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 199. AMERICAS CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 200. AMERICAS CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 201. AMERICAS CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY CNS, 2018-2024 (USD MILLION)
TABLE 202. AMERICAS CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY CNS, 2025-2030 (USD MILLION)
TABLE 203. AMERICAS CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 204. AMERICAS CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 205. AMERICAS CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 206. AMERICAS CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 207. AMERICAS CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 208. AMERICAS CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 209. AMERICAS CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
TABLE 210. AMERICAS CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY CLOUD, 2025-2030 (USD MILLION)
TABLE 211. AMERICAS CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY ON PREMISE, 2018-2024 (USD MILLION)
TABLE 212. AMERICAS CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY ON PREMISE, 2025-2030 (USD MILLION)
TABLE 213. AMERICAS CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 214. AMERICAS CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 215. UNITED STATES CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 216. UNITED STATES CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 217. UNITED STATES CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY AUDIT INSPECTION READINESS, 2018-2024 (USD MILLION)
TABLE 218. UNITED STATES CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY AUDIT INSPECTION READINESS, 2025-2030 (USD MILLION)
TABLE 219. UNITED STATES CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY CASE PROCESSING, 2018-2024 (USD MILLION)
TABLE 220. UNITED STATES CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY CASE PROCESSING, 2025-2030 (USD MILLION)
TABLE 221. UNITED STATES CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY REGULATORY INTELLIGENCE, 2018-2024 (USD MILLION)
TABLE 222. UNITED STATES CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY REGULATORY INTELLIGENCE, 2025-2030 (USD MILLION)
TABLE 223. UNITED STATES CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY RISK MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 224. UNITED STATES CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY RISK MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 225. UNITED STATES CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY SIGNAL DETECTION, 2018-2024 (USD MILLION)
TABLE 226. UNITED STATES CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY SIGNAL DETECTION, 2025-2030 (USD MILLION)
TABLE 227. UNITED STATES CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 228. UNITED STATES CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 229. UNITED STATES CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY CRO, 2018-2024 (USD MILLION)
TABLE 230. UNITED STATES CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY CRO, 2025-2030 (USD MILLION)
TABLE 231. UNITED STATES CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY MEDICAL DEVICE MANUFACTURERS, 2018-2024 (USD MILLION)
TABLE 232. UNITED STATES CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY MEDICAL DEVICE MANUFACTURERS, 2025-2030 (USD MILLION)
TABLE 233. UNITED STATES CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY PHARMA BIOTECH, 2018-2024 (USD MILLION)
TABLE 234. UNITED STATES CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY PHARMA BIOTECH, 2025-2030 (USD MILLION)
TABLE 235. UNITED STATES CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY CLINICAL TRIAL PHASE, 2018-2024 (USD MILLION)
TABLE 236. UNITED STATES CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY CLINICAL TRIAL PHASE, 2025-2030 (USD MILLION)
TABLE 237. UNITED STATES CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY PHASE I, 2018-2024 (USD MILLION)
TABLE 238. UNITED STATES CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY PHASE I, 2025-2030 (USD MILLION)
TABLE 239. UNITED STATES CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY PHASE II, 2018-2024 (USD MILLION)
TABLE 240. UNITED STATES CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY PHASE II, 2025-2030 (USD MILLION)
TABLE 241. UNITED STATES CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY PHASE III, 2018-2024 (USD MILLION)
TABLE 242. UNITED STATES CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY PHASE III, 2025-2030 (USD MILLION)
TABLE 243. UNITED STATES CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY PHASE IV, 2018-2024 (USD MILLION)
TABLE 244. UNITED STATES CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY PHASE IV, 2025-2030 (USD MILLION)
TABLE 245. UNITED STATES CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 246. UNITED STATES CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 247. UNITED STATES CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 248. UNITED STATES CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 249. UNITED STATES CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY CNS, 2018-2024 (USD MILLION)
TABLE 250. UNITED STATES CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY CNS, 2025-2030 (USD MILLION)
TABLE 251. UNITED STATES CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 252. UNITED STATES CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 253. UNITED STATES CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 254. UNITED STATES CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 255. UNITED STATES CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 256. UNITED STATES CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 257. UNITED STATES CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
TABLE 258. UNITED STATES CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY CLOUD, 2025-2030 (USD MILLION)
TABLE 259. UNITED STATES CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY ON PREMISE, 2018-2024 (USD MILLION)
TABLE 260. UNITED STATES CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY ON PREMISE, 2025-2030 (USD MILLION)
TABLE 261. UNITED STATES CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 262. UNITED STATES CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 263. CANADA CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 264. CANADA CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 265. CANADA CLINICAL SAFETY & PHARMACOVIGILANCE SERVICES MARKET SIZE, BY AUDIT INSPECTION READINESS,

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Clinical Safety & Pharmacovigilance Services Market report include:
  • IQVIA Holdings Inc.
  • Laboratory Corporation of America Holdings
  • Thermo Fisher Scientific Inc.
  • Parexel International Corporation
  • ICON plc
  • Syneos Health, Inc.
  • Accenture plc
  • Cognizant Technology Solutions Corporation
  • Wipro Limited
  • Genpact Limited

Related Topics

Related Reports

Pharmacovigilance Market - Global Forecast 2025-2030 - Product Image

Pharmacovigilance Market - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
Pharmacovigilance Market Size, Share & Trends Analysis Report By Product Life Cycle, By Service Provider (In-house, Contract Outsourcing), By Type, By Therapeutic Area, By Process Flow, By End Use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Pharmacovigilance Market Size, Share & Trends Analysis Report By Product Life Cycle, By Service Provider (In-house, Contract Outsourcing), By Type, By Therapeutic Area, By Process Flow, By End Use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
Pharmacovigilance & Drug Safety Software Market - Global Forecast 2025-2030 - Product Image

Pharmacovigilance & Drug Safety Software Market - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
Pharmacovigilance Market Report 2025 - Product Image

Pharmacovigilance Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Pharmacovigilance - Global Strategic Business Report - Product Image

Pharmacovigilance - Global Strategic Business Report

  • Report
  • 473 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.